The timely importance of our study reflects the recent publication and implementation of the National Health Service England (NHSE) national test directory.13 In England, testing for only BRCA1, BRCA2, and PALB2 PGVs is offered for hereditary breast cancer. This evidence concerns the gene BRCA2 and Hereditary breast cancer.